Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -802.00 | 34.87k | Derivative Exercise and Sale | 58.22 | 28.68k | - |
| 2026-05-01 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 571.00 | 0.00 | Derivative Exercise and Retained Stock | - | 28.68k | 2.03% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 1.62k | 0.00 | Derivative Exercise and Retained Stock | - | 27.35k | 6.28% |
| 2026-04-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -1.69k | 104.45k | Derivative Exercise and Sale | 61.73 | 27.35k | - |
| 2026-04-01 | Mr. David V. ElkinsExec. VP & CFO | -30.00k | 1.85M | Automatic Disposition | 61.60 - 62.05 | 159.54k | -15.83% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 2.25k | 0.00 | Derivative Exercise and Retained Stock | - | 7.92k | 39.65% |
| 2026-03-10 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -3.64k | 76.67k | Derivative Exercise and Sale | 60.13 | 7.92k | - |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 7.41k | 0.00 | Derivative Exercise and Retained Stock | - | 25.55k | 40.83% |
| 2026-03-10 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -18.09k | 466.61k | Derivative Exercise and Sale | 60.13 | 25.55k | - |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | 5.69k | 0.00 | Derivative Exercise and Retained Stock | - | 24.75k | 29.84% |
| 2026-03-10 | Dr. Robert M. PlengeExec. VP & Chief Research Officer | -11.81k | 272.69k | Derivative Exercise and Sale | 60.13 | 24.75k | - |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 8.93k | 0.00 | Derivative Exercise and Retained Stock | - | 30.36k | 41.69% |
| 2026-03-10 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -16.96k | 395.78k | Derivative Exercise and Sale | 60.13 | 30.36k | - |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | 6.70k | 0.00 | Derivative Exercise and Retained Stock | - | 27.91k | 31.56% |
| 2026-03-10 | Mr. Adam LenkowskyExec. VP & Chief Commercialization Officer | -17.38k | 421.81k | Derivative Exercise and Sale | 60.13 | 27.91k | - |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | 2.40k | 0.00 | Derivative Exercise and Retained Stock | - | 17.36k | 16.00% |
| 2026-03-10 | Mr. Phil M. HolzerSenior VP & Controller | -3.80k | 81.66k | Derivative Exercise and Sale | 60.13 | 17.36k | - |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | 3.50k | 0.00 | Derivative Exercise and Retained Stock | - | 8.21k | 74.27% |
| 2026-03-10 | Ms. Lynelle B. HochPresident of Cell Therapy Organization | -4.69k | 83.64k | Derivative Exercise and Sale | 60.13 | 8.21k | - |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2.07k | 0.00 | Derivative Exercise and Retained Stock | - | 13.13k | 18.66% |
| 2026-03-10 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -4.92k | 130.18k | Derivative Exercise and Sale | 60.13 | 13.13k | - |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | 1.90k | 0.00 | Derivative Exercise and Retained Stock | - | 7.32k | 35.03% |
| 2026-03-10 | Ms. Ahn Amanda PooleExec. VP & CPO | -4.54k | 119.78k | Derivative Exercise and Sale | 60.13 | 7.32k | - |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | 20.27k | 0.00 | Derivative Exercise and Retained Stock | - | 146.89k | 16.01% |
| 2026-03-10 | Dr. Christopher S. BoernerCEO & Chairman | -51.27k | 1.28M | Derivative Exercise and Sale | 60.13 | 146.89k | - |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | 21.87k | 0.00 | Derivative Exercise and Retained Stock | - | 189.54k | 13.04% |
| 2026-03-10 | Mr. David V. ElkinsExec. VP & CFO | -41.11k | 968.93k | Derivative Exercise and Sale | 60.13 | 189.54k | - |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | 1.61k | 0.00 | Derivative Exercise and Retained Stock | - | 16.67k | 10.72% |
| 2026-02-27 | Mr. Benjamin J. HickeyPresident of RayzeBio | -1.67k | 104.28k | Derivative Exercise and Sale | 62.37 | 16.67k | - |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 1.71k | 0.00 | Derivative Exercise and Retained Stock | - | 21.43k | 8.67% |
| 2026-02-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -833.00 | 45.86k | Derivative Exercise and Sale | 55.05 | 21.43k | - |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | 6.27k | 0.00 | Derivative Exercise and Retained Stock | - | 15.06k | 71.33% |
| 2026-02-01 | Mr. Benjamin J. HickeyPresident of RayzeBio | -3.81k | 209.74k | Derivative Exercise and Sale | 55.05 | 15.06k | - |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | 1.18k | 0.00 | Derivative Exercise and Retained Stock | - | 126.62k | 0.94% |
| 2025-11-01 | Dr. Christopher S. BoernerCEO & Chairman | -1.78k | 57.03k | Derivative Exercise and Sale | 46.07 | 126.62k | - |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | 3.62k | 0.00 | Derivative Exercise and Retained Stock | - | 19.72k | 22.46% |
| 2025-11-01 | Mr. Greg MeyersExec. VP and Chief Digital & Technology Officer | -2.67k | 122.78k | Derivative Exercise and Sale | 46.07 | 19.72k | - |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | 3.07k | 0.00 | Derivative Exercise and Retained Stock | - | 18.14k | 20.35% |
| 2025-11-01 | Ms. Karin ShanahanExec. VP, Chief Supply Chain & Operations Officer | -3.21k | 148.02k | Derivative Exercise and Sale | 46.07 | 18.14k | - |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 2.23k | 0.00 | Derivative Exercise and Retained Stock | - | 11.07k | 25.18% |
| 2025-10-02 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -2.33k | 106.64k | Derivative Exercise and Sale | 45.73 | 11.07k | - |
| 2025-09-02 | Mr. David V. ElkinsExec. VP & CFO | -56.00k | 2.65M | Automatic Disposition | 47.33 | 167.66k | -25.04% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 603.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.67k | 11.90% |
| 2025-09-01 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -632.00 | 29.82k | Derivative Exercise and Sale | 47.18 | 5.67k | - |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | 518.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.84k | 6.22% |
| 2025-08-01 | Ms. Cari GallmanExec. VP, General Counsel & Chief Policy Officer | -543.00 | 24.02k | Derivative Exercise and Sale | 44.23 | 8.84k | - |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | 360.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.07k | 7.65% |
| 2025-08-02 | Ms. Wendy Short BartieExec. VP & Chief Corporate Affairs Officer | -378.00 | 16.72k | Derivative Exercise and Sale | 44.23 | 5.07k | - |
| 2025-06-13 | Dr. Christopher S. BoernerCEO & Chairman | -62.72k | 0.00 | Other Disposition | - | 125.44k | -33.33% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
